“Repurposing of Thalidomide As a Potential Therapeutic Agent for Idiopathic Pulmonary Fibrosis: An In Silico Molecular Docking Study”. International Journal of Research in Pharmaceutical Sciences and Technology, vol. 9, no. 3, Aug. 2026, https://doi.org/10.33974/st7x9s50.